Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

Malignant pleural mesothelioma is an aggressive tumor that has a poor prognosis and is resistant to unimodal approaches. Multimodal treatment has provided encouraging results.Phase II, open-label study of the combination of chemotherapy (pemetrexed 500 mg/m²+cisplatin 75 mg/m² IV every 21 days × 3 c...

Full description

Saved in:
Bibliographic Details
Main Authors: Rea Federico, Adolfo Favaretto, Giuseppe Marulli, Lorenzo Spaggiari, DePas Tommaso Martino, Ceribelli Anna, Adriano Paccagnella, Gino Crivellari, Russo Francesca, Matteo Ceccarelli, Kazeem Gbenga, Marchi Paolo, Francesco Facciolo
Format: Artigo
Language:English
Published: 2013
Online Access:https://doi.org/10.1186/1471-2407-13-22
Tags: Add Tag
No Tags, Be the first to tag this record!